During the last session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 0.27 million, with the beta value of the company hitting 2.02. At the end of the trading day, the stock’s price was $3.25, reflecting an intraday loss of -10.22% or -$0.37. The company’s market capitalization is $2.46M, and the average trade volume was 210.65K shares over the past three months.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Conduit Pharmaceuticals Inc (CDT) registered a -10.22% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -10.22% in intraday trading to $3.25, hitting a weekly high. The stock’s 5-day price performance is -20.92%, and it has moved by -61.17% in 30 days. Based on these gigs, the overall price performance for the year is -99.93%.

CDT Dividends

Conduit Pharmaceuticals Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 0.69 million shares, is of BLACKROCK INC.’s that is approximately 0.0187% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.73 million.

Also, the Mutual Funds coming in first place with the largest holdings of Conduit Pharmaceuticals Inc (CDT) shares are Fidelity Salem Street Trust-Fidelity Small Cap Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . Data provided on Feb 28, 2025 indicates that Fidelity Salem Street Trust-Fidelity Small Cap Index Fund owns about 855.0 shares. This amounts to just over 0.11 percent of the company’s overall shares, with a $2778.0 market value. The same data shows that the other fund manager holds slightly less at 311.0, or about 0.04% of the stock, which is worth about $1010.0.